Debra L. Hanson

8.4k total citations · 2 hit papers
105 papers, 6.2k citations indexed

About

Debra L. Hanson is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Debra L. Hanson has authored 105 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Infectious Diseases, 54 papers in Virology and 41 papers in Epidemiology. Recurrent topics in Debra L. Hanson's work include HIV/AIDS Research and Interventions (62 papers), HIV Research and Treatment (54 papers) and HIV/AIDS drug development and treatment (29 papers). Debra L. Hanson is often cited by papers focused on HIV/AIDS Research and Interventions (62 papers), HIV Research and Treatment (54 papers) and HIV/AIDS drug development and treatment (29 papers). Debra L. Hanson collaborates with scholars based in United States, Uganda and Switzerland. Debra L. Hanson's co-authors include Mark S. Dworkin, Jeffrey L. Jones, Patrick S. Sullivan, Jonathan E. Kaplan, Scott D. Holmberg, John W. Ward, A. D. McNaghten, Toni Frederick, John T. Brooks and Susan Y. Chu and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Debra L. Hanson

103 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003

2008 671 citations Debra L. Hanson, Patrick S. Sullivan et al. profile →
Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy

2000 556 citations Jonathan E. Kaplan, Debra L. Hanson et al. Clinical Infectious Diseases profile →

Peers

Debra L. Hanson

EPIDE

VIROL

ONCOL

Shinichi Oka Japan

Richard C. Reichman United States

Brian K. Agan United States

Keith Henry United States

Niels Obel Denmark

Koya Ariyoshi Japan

H. W. Jaffe United States

Jean‐François Delfraissy France

Jan Gerstoft Denmark

Sheldon H. Landesman United States

Shinichi Oka Japan

Debra L. Hanson

4.3k ×1.1

2.8k ×0.8

EPIDE

3.2k ×1.7

VIROL

610 ×0.8

ONCOL

879 ×1.4

Citations per year, relative to Debra L. Hanson Debra L. Hanson (= 1×) peers Shinichi Oka

Countries citing papers authored by Debra L. Hanson

Since Specialization

Citations

This map shows the geographic impact of Debra L. Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra L. Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra L. Hanson more than expected).

Fields of papers citing papers by Debra L. Hanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra L. Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra L. Hanson. The network helps show where Debra L. Hanson may publish in the future.

Co-authorship network of co-authors of Debra L. Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of Debra L. Hanson. A scholar is included among the top collaborators of Debra L. Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra L. Hanson. Debra L. Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garfein, Richard S., Elizabeth T. Golub, Alan E. Greenberg, et al.. (2018). A peer-education intervention to reduce injection risk behaviors for HIV and HCV infection in young injection drug users.. eScholarship (California Digital Library).

Kassanjee, Reshma, Daniela De Angelis, Debra L. Hanson, et al.. (2017). Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the ‘Mean Duration of Recent Infection’. PubMed. 9(1). 6 indexed citations

Henning, Tara, Debra L. Hanson, Sundaram A. Vishwanathan, et al.. (2014). Short Communication: Viremic Control Is Independent of Repeated Low-Dose SHIV _SF162p3 Exposures. AIDS Research and Human Retroviruses. 30(11). 1125–1129. 3 indexed citations

Butler, Katherine, Jennifer Morgan, Debra L. Hanson, et al.. (2013). Susceptibility to Repeated, Low-Dose, Rectal SHIV _SF162P3 Challenge Is Independent of TRIM5 Genotype in Rhesus Macaques. AIDS Research and Human Retroviruses. 29(7). 1091–1094. 5 indexed citations

Cong, Mian‐er, James Mitchell, Elizabeth Sweeney, et al.. (2013). Prophylactic Efficacy of Oral Emtricitabine and Tenofovir Disoproxil Fumarate Combination Therapy Against a Tenofovir-Resistant Simian/Human Immunodeficiency Virus Containing the K65R Mutation in Macaques. The Journal of Infectious Diseases. 208(3). 463–467. 15 indexed citations

Kersh, Ellen N., Wei Luo, Qi Zheng, et al.. (2012). Reduced Inflammation and CD4 Loss in Acute SHIV Infection During Oral Pre-Exposure Prophylaxis. The Journal of Infectious Diseases. 206(5). 770–779. 13 indexed citations

Mei, Joanne V., Laurie Linley, Debra L. Hanson, et al.. (2011). Standardization and Monitoring of Laboratory Performance and Quality Assurance by Use of the Less-Sensitive HIV Incidence Assay. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(5). 482–488. 5 indexed citations

Hanson, Debra L., Priya Srinivasan, Wei Luo, et al.. (2010). Resistance to Simian HIV Infection Is Associated With High Plasma Interleukin-8, RANTES and Eotaxin in a Macaque Model of Repeated Virus Challenges. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(5). 574–581. 15 indexed citations

Parekh, Bharat, Debra L. Hanson, John W. Hargrove, et al.. (2010). Determination of Mean Recency Period for Estimation of HIV Type 1 Incidence with the BED-Capture EIA in Persons Infected with Diverse Subtypes. AIDS Research and Human Retroviruses. 27(3). 265–273. 73 indexed citations

10.

Reed, Jason, Debra L. Hanson, A. D. McNaghten, et al.. (2009). HIV Testing Factors Associated with Delayed Entry into HIV Medical Care among HIV-Infected Persons from Eighteen States, United States, 2000–2004. AIDS Patient Care and STDs. 23(9). 765–773. 47 indexed citations

11.

Adjé-Touré, Christiane, Debra L. Hanson, Marie-Yolande Borget, et al.. (2008). Virologic and Immunologic Response to Antiretroviral Therapy and Predictors of HIV Type 1 Drug Resistance in Children Receiving Treatment in Abidjan, Côte d'Ivoire. AIDS Research and Human Retroviruses. 24(7). 911–917. 41 indexed citations

12.

Hanson, Debra L., et al.. (2007). HIV-infected Injection Drug Users: Health Care Utilization and Morbidity. Journal of Health Care for the Poor and Underserved. 18(3). 675–686. 18 indexed citations

13.

Sullivan, Patrick S., Debra L. Hanson, Eyasu H. Teshale, Linda L. Wotring, & John T. Brooks. (2006). Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. AIDS. 20(8). 1171–1179. 52 indexed citations

14.

Brooks, John T., et al.. (2005). Discontinuation of Primary Prophylaxis against Mycobacterium avium Complex Infection in HIV-Infected Persons Receiving Antiretroviral Therapy: Observations from a Large National Cohort in the United States, 1992-2002. Clinical Infectious Diseases. 41(4). 549–553. 8 indexed citations

15.

Dworkin, Mark S., et al.. (2001). Survival of Patients with AIDS, after Diagnosis ofPneumocystis cariniiPneumonia, in the United States. The Journal of Infectious Diseases. 183(9). 1409–1412. 33 indexed citations

16.

Kaplan, Jonathan E., Debra L. Hanson, Mark S. Dworkin, et al.. (2000). Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 30(s1). S5–S14. 556 indexed citations breakdown →

17.

McNaghten, A. D., Debra L. Hanson, Jeffery L. Jones, Mark S. Dworkin, & John W. Ward. (1999). Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. AIDS. 13(13). 1687–1695. 128 indexed citations

18.

Jones, Joyce, Debra L. Hanson, Mark S. Dworkin, John Kaplan, & Jennifer Ward. (1998). Trends in AIDS-Related Opportunistic Infections among Men Who Have Sex with Men and among Injecting Drug Users, 1991-1996. The Journal of Infectious Diseases. 178(1). 114–120. 48 indexed citations

19.

Horsburgh, C. Robert, Debra L. Hanson, J. L. Jones, & Suzanne Thompson. (1996). Protection from Mycobacterium avium Complex Disease in Human Immunodeficiency Virus-Infected Persons with a History of Tuberculosis. The Journal of Infectious Diseases. 174(6). 1212–1217. 35 indexed citations

20.

Simonds, R. J., Mary Lou Lindegren, Debra L. Hanson, et al.. (1995). Prophylaxis againstPneumocystis cariniiPneumonia among Children with Perinatally Acquired Human Immunodeficiency Virus Infection in the United States. New England Journal of Medicine. 332(12). 786–790. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact